Thermo Fisher Scientific : Plans $130 Million Sterile Filling Plant in Singapore

By Colin Kellaher

Thermo Fisher Scientific Inc. on Wednesday said it plans to build a $130 million sterile filling plant in Singapore, extending its capacity to develop and manufacture therapies and vaccines to the Asia-Pacific region.

The Waltham, Mass., life-sciences company said the plant, when operational in 2022, will have the capacity to make up to 30 million sterile doses a month and employ more than 300 people.

Thermo Fisher said the new plant will initially include a high-speed sterile line approved for live virus filling, followed by an additional line for standard fill/finish. The facility will also have cleanroom capacity, labs, warehousing and offices to support production, the company said.

Thermo Fisher said the plant, established with the support of the Singapore Economic Development Board, will bolster the Singapore government's ability to respond quickly to future health crises such as the Covid-19 pandemic.

Write to Colin Kellaher at [e-mail]

(END) Dow Jones Newswires

10-14-20 0839ET